SYS-6002
- Generic Name
- SYS-6002
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Corbus Pharmaceuticals Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT06265727
- Locations
- 🇺🇸
O'Neal Comprehensive Cancer Center at University of Alabama-Birmingham, Birmingham, Alabama, United States
🇺🇸City of Hope Cancer Center, Duarte, California, United States
🇺🇸Moores Cancer Centre at UC San Diego Health, San Diego, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath